Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Corteva, Inc. (CTVA)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
60.27+0.33 (+0.55%)
At close: 04:03PM EDT
58.85 -1.42 (-2.36%)
After hours: 07:45PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • R
    Richard
    CTVA could be in a good spot as the world works through the Ukraine food crisis. Same for Sri Lanka, etc. I am going long here and will use option strategies to pay for the buy in.
  • P
    Paula
    Corteva fans might find S&W Seed Company (SANW) of interest.
  • N
    None
    Ah is good...about the only good news today.
  • c
    cj
    Ctva headed towards $50. Wonder what's causing that
  • R
    Robert
    By far the best performer of the three companies from the break up...Dow, Dupont and Corteva.
  • g
    george
    I am long on ctva. It is a company that makes sense to me. I inherited out of the spin off, but after reading up on the company, I began to appreciate it more. Then the news came that the hedge fund bought a position and wrote that ctva has untapped potential. That report added $2 to the share price and it is holding it. So, should I buy another 100 shares? Is this stock going to move above $40 in the next year? Will they bump the dividend?
  • J
    John
    what was this co formally known as?
  • w
    william
    I own this stock and read the message board, I also own new DD but there is no conversation for it WHY?
  • J
    JohnB
    What happened today to cause a sudden 5% drop?
  • s
    sylycaqa
    I had received ~250 shares of CTVA after DOW spun off DD and CTVA Aug 2019 - I held on to them (they had a $10.95 basis from the spinoff) and they have become my best trade appreciating over 400%.
  • g
    glen
    Both Syngenta and Bayer are struggling with their seeds businesses. CTVA has an opportunity to break free of license costs and expand its customer base with its products. And its Ag Chem offerings are expanding and growing nicely. The Seeds and Ag Chem markets are highly cyclical boom and bust - as is the production agriculture industry as a whole. A good cycle is ahead, especially with less friction between the US and China. Should be positive for CTVA. My view - stick with current management team - they know the business and industry. The Starboard sharks are just after a short term sugar high - reject them. My view.
  • R
    Robert
    Corteva and competitors are in the process of refunding seeds and chemicals to farmers unable to plant this season due to weather.
    Corteva is a long term play with significant upside potential, not a stock for short term, emotional investors.
  • D
    Dan
    Seed orders should be rolling in...Looks to be a big year!
  • J
    JIII
    For now I am sticking with current management and their slate of directors. The company has hardly had time to perform on its own and COVID has not helped.
  • w
    william
    What if any does this stock pay on dividends? there is no information on the ticker it says N/A
  • G
    Greg
    the merger was a desaster for investors
  • J
    Juan
    Despite the ups and downs in the short term Corteva owns the highest number of patents in Crispr, a new engineering tool. Considering that this technique is relatively new, it is very interesting to observe how Corteva has been investing time and resources in research, so that it currently leads the number of patents, even more than Bayer. I think this research into modification of seeds will give very good profits.
  • B
    BR549
    Corteva announced a $.13/qtr dividend today & a $1 billion stock buyback. Shooting for a 25-35% of net income for dividends in the future. Good to hear.
  • S
    Scott
    Corteva is easily the best of the Dupont spinoffs... This will be $40+/- in 12-18 months and will continue to grow nicely long term from there. Profits will really take off in 2023 when the $1B annual RoundUp licensing fee expires. Folks worried about a couple bucks near term are going to miss out on the huge gains longer term. I'll start buy more if/when we see $24-ish prices again. If not, I'm happy with what I already own.
  • D
    Dan
    Dang good quarter!
Advertisement
Advertisement